Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2005 (Vol. 25, No. 4)

Swiss EMBnet Node Server

URL:www.ch.embnet.org/index.html
  • Excellent Tools
  • None
If you are serious about sequence analysis, you probably already know of this site. The Swiss EMBnet Node Server takes no prisoners. A quick glance at its opening page provides a view of a jaw-dropping collection of online tools, links, and even courses taught at various European institutions. Analysis tools include iPCR (virtual PCR), sequence alignments, protein domain predictions, a promoter database, signal sequence searches, and access to downloadable databases and information by FTP. There is extensive documentation available and the collection of links is superb. Last, a section called Contacts provides (in addition to contact information) a listing of jobs and access to email lists. There’s something for everyone at the Swiss EMBnet Node Server.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »